Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H20N2O2 |
Molecular Weight | 272.3422 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(C)C(=O)OC1=CC2=C(CC[C@H]2NCC#C)C=C1
InChI
InChIKey=LHXOCOHMBFOVJS-OAHLLOKOSA-N
InChI=1S/C16H20N2O2/c1-4-10-17-15-9-7-12-6-8-13(11-14(12)15)20-16(19)18(3)5-2/h1,6,8,11,15,17H,5,7,9-10H2,2-3H3/t15-/m1/s1
Molecular Formula | C16H20N2O2 |
Molecular Weight | 272.3422 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
LADOSTIGIL, a rasagiline derivative, is a reversible acetylcholinesterase and butyrylcholinesterase inhibitor with neuroprotective properties. It also acts as an irreversible brain monoamine oxidases inhibitor. It is under development for the treatment of neurodegenerative disorders like dementia and Alzheimer's disease.
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Protein 4.1N is required for translocation of inositol 1,4,5-trisphosphate receptor type 1 to the basolateral membrane domain in polarized Madin-Darby canine kidney cells. | 2003 Feb 7 |
|
Effect of chronic treatment with ladostigil (TV-3326) on anxiogenic and depressive-like behaviour and on activity of the hypothalamic-pituitary-adrenal axis in male and female prenatally stressed rats. | 2005 Aug |
|
Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. | 2005 Feb |
|
Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy. | 2007 Dec |
|
The application of proteomics and genomics to the study of age-related neurodegeneration and neuroprotection. | 2007 Feb |
|
Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro. | 2007 Oct |
|
The neurotrophic and neuroprotective effects of psychotropic agents. | 2009 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:45:17 GMT 2023
by
admin
on
Sat Dec 16 17:45:17 GMT 2023
|
Record UNII |
SW3H1USR4Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C667
Created by
admin on Sat Dec 16 17:45:18 GMT 2023 , Edited by admin on Sat Dec 16 17:45:18 GMT 2023
|
||
|
NCI_THESAURUS |
C47792
Created by
admin on Sat Dec 16 17:45:18 GMT 2023 , Edited by admin on Sat Dec 16 17:45:18 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL255231
Created by
admin on Sat Dec 16 17:45:18 GMT 2023 , Edited by admin on Sat Dec 16 17:45:18 GMT 2023
|
PRIMARY | |||
|
100000153824
Created by
admin on Sat Dec 16 17:45:18 GMT 2023 , Edited by admin on Sat Dec 16 17:45:18 GMT 2023
|
PRIMARY | |||
|
SW3H1USR4Q
Created by
admin on Sat Dec 16 17:45:18 GMT 2023 , Edited by admin on Sat Dec 16 17:45:18 GMT 2023
|
PRIMARY | |||
|
209394-27-4
Created by
admin on Sat Dec 16 17:45:18 GMT 2023 , Edited by admin on Sat Dec 16 17:45:18 GMT 2023
|
PRIMARY | |||
|
208907
Created by
admin on Sat Dec 16 17:45:18 GMT 2023 , Edited by admin on Sat Dec 16 17:45:18 GMT 2023
|
PRIMARY | |||
|
DTXSID101045854
Created by
admin on Sat Dec 16 17:45:18 GMT 2023 , Edited by admin on Sat Dec 16 17:45:18 GMT 2023
|
PRIMARY | |||
|
SUB128273
Created by
admin on Sat Dec 16 17:45:18 GMT 2023 , Edited by admin on Sat Dec 16 17:45:18 GMT 2023
|
PRIMARY | |||
|
C77584
Created by
admin on Sat Dec 16 17:45:18 GMT 2023 , Edited by admin on Sat Dec 16 17:45:18 GMT 2023
|
PRIMARY | |||
|
8353
Created by
admin on Sat Dec 16 17:45:18 GMT 2023 , Edited by admin on Sat Dec 16 17:45:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|